Page last updated: 2024-10-25

cystamine and Leprosy

cystamine has been researched along with Leprosy in 1 studies

Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.

Research Excerpts

ExcerptRelevanceReference
"This reports a long-term follow-up study on clinical effects of ofloxacin (OFLX)-combined therapy to 14 leprosy patients with various types and stages."7.74[Long-term follow-up of ofloxacin-combined therapy for leprosy patients]. ( Ishikawa, M; Ozaki, M, 2007)
"This reports a long-term follow-up study on clinical effects of ofloxacin (OFLX)-combined therapy to 14 leprosy patients with various types and stages."3.74[Long-term follow-up of ofloxacin-combined therapy for leprosy patients]. ( Ishikawa, M; Ozaki, M, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ozaki, M1
Ishikawa, M1

Other Studies

1 other study available for cystamine and Leprosy

ArticleYear
[Long-term follow-up of ofloxacin-combined therapy for leprosy patients].
    Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association, 2007, Volume: 76, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Clofazimine; Cystamine; Drug Therapy, Combination; Follow-Up Studies; H

2007